Oman Pharmaceuticals and Healthcare Report Q3 2013

Date: May 29, 2013
Pages: 102
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O611450F1BFEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Although one of the smallest healthcare markets in the Gulf Cooperation Council, Oman boasts a 10-year compound annual growth rate of 9% in US dollar terms, a figure in line with large regional players Saudi Arabia and the UAE. The reasons behind this are two-fold. Public and foreign private investment in the planning and construction of two US$1bn medical cities will see Oman become a regional medical tourism hub in the long term. Meanwhile, government policies will see the healthcare financial burden gradually shift towards the more lucrative private healthcare market with continuing foreign direct investment in the sector.

Headline Expenditure Projections
  • Pharmaceuticals: OMR166mn (US$433mn) in 2012 to OMR181mn (US$477mn) in 2013; 9.3% in local currency terms and +10.7% in US dollar terms. Forecast broadly in line with Q213.
  • Healthcare: OMR709mn (US$1.84bn) in 2012 to OMR770mn (US$2.03bn) in 2012; +8.6% in local currency terms and +10.0 in US dollar terms. Forecast revised slightly downwards due to modifications to historical figures.
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Oman Pharmaceutical Sales, Historical Data And Forecasts, 2009-2017
Healthcare Market Forecast
  Table: Oman Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
  Table: Oman Government Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017
  Table: Oman Private Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017
Prescription Drug Market Forecast
  Table: Oman Prescription Drug Market Indicators, Historical Data And Forecasts, 2009-2017
Patented Drug Market Forecast
  Table: Oman Patented Drug Market Indicators, Historical Data And Forecasts
Generic Drug Market Forecast
  Table: Oman Generic Drug Market Indicators, Historical Data And Forecasts, 2009-2017
OTC Medicine Market Forecast
  Table: Oman Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts, 2009-2017
Pharmaceutical Trade Forecast
  Table: Oman Pharmaceutical Trade Data And Forecasts (US$mn), 2009-2017
  Table: Oman Pharmaceutical Trade Data And Forecasts (OMRmn), 2009-2017
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
  Table: Oman - Economic Activity
Industry Risk Reward Ratings
Middle East And Africa Risk/Reward Ratings
Oman Risk/Reward Ratings
Rewards
Risks
Market Overview
Industry Trends And Developments
Industry Trends And Developments
Epidemiology
Communicable Diseases
Non-Communicable Diseases
Public Health Developments
Healthcare Sector
  Table: Number Of Health Centres In Oman By Region
  Table: Number And Type Of Health Institutions In Oman In 2011
Healthcare System Developments
  Table: Healthcare Reform Targets
Private Healthcare Sector
Private Healthcare Developments
Healthcare Insurance
Telemedicine
Medical Tourism
Research And Development
Clinical Trials
Regulatory Development
Regulatory Developments
Intellectual Property Regime
Regional Harmonisation
Pricing And Reimbursement Regime
Competitive Landscape
Domestic Pharmaceutical Industry
Foreign Pharmaceutical Industry
Pharmaceutical Distribution
Company Profile
Zynova/Oman Pharmaceutical Products Company
National Pharmaceutical Industries (NPI)
Novartis
GlaxoSmithKline
Sanofi
Johnson & Johnson
Demographic Forecast
  Table: Oman's Population By Age Group, 1990-2020 ('000)
  Table: Oman's Population By Age Group, 1990-2020 (% of total)
  Table: Oman's Key Population Ratios, 1990-2020
  Table: Oman's Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings
Oman Pharmaceuticals and Healthcare Report Q4 2013 US$ 1,295.00 Sep, 2013 · 97 pages
Oman Pharmaceuticals and Healthcare Report Q1 2014 US$ 1,295.00 Nov, 2013 · 102 pages

Ask Your Question

Oman Pharmaceuticals and Healthcare Report Q3 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: